BIOCRYST PHARMACEUTICALS INC·4

Sep 5, 4:41 PM ET

HEGGIE THERESA 4

4 · BIOCRYST PHARMACEUTICALS INC · Filed Sep 5, 2023

Insider Transaction Report

Form 4
Period: 2023-08-31
Transactions
  • Award

    Common Stock

    2023-08-31$7.11/sh+791$5,62449,905 total
Footnotes (1)
  • [F1]Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT